{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:19:30Z","timestamp":1770977970949,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.jhep.2012.05.018","type":"journal-article","created":{"date-parts":[[2012,6,3]],"date-time":"2012-06-03T07:49:33Z","timestamp":1338709773000},"page":"736-742","source":"Crossref","is-referenced-by-count":15,"title":["A population-based study of the epidemiology of hepatitis C in a North American population"],"prefix":"10.1016","volume":"57","author":[{"given":"Julia","family":"Uhanova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert B","family":"Tate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas J","family":"Tataryn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald Y","family":"Minuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jhep.2012.05.018_b0005","article-title":"Weekly Epidemiological Record","volume":"49","author":"World Health Organization","year":"1999","journal-title":"WHO"},{"key":"10.1016\/j.jhep.2012.05.018_b0010","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States 1999 through 2002","volume":"144","author":"Armstrong","year":"2006","journal-title":"Ann Int Med"},{"key":"10.1016\/j.jhep.2012.05.018_b0015","unstructured":"Remis RS. Modelling the Incidence and Prevalence of Hepatitis C Infection and its Sequelae in Canada. 2007. Final Report. HP40-39\/2009E-PDF; 978-1-100-12614-2. www.phac-aspc.gc.ca\/sti-its-surv-epi\/model\/index-eng.php."},{"key":"10.1016\/j.jhep.2012.05.018_b0020","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.2496467","article-title":"An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis","volume":"244","author":"Kuo","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jhep.2012.05.018_b0025","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1139\/w06-056","article-title":"Hepatitis C virus infection among First Nation and non-First Nation people in Manitoba, Canada \u2014 a public health laboratory study","volume":"52","author":"Dawood","year":"2006","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.jhep.2012.05.018_b0030","unstructured":"Manitoba Health. Population tables http:\/\/www.manitoba.ca\/health."},{"key":"10.1016\/j.jhep.2012.05.018_b0035","unstructured":"CCSD\u2019s Stats & Facts: Demographic Profile of Canada. http:\/\/www.ccsd.ca\/factsheets\/demographics\/demographics.pdf."},{"key":"10.1016\/j.jhep.2012.05.018_b0040","unstructured":"Public Health Agency of Canada, Disease Surveillance, Notifiable Diseases on Line, www.dsol-smed.phac-aspc.gc.ca\/dsol-smed\/ndis\/index_e.html."},{"key":"10.1016\/j.jhep.2012.05.018_b0045","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1080\/00365520310004542","article-title":"Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum","volume":"38","author":"Dalgard","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2012.05.018_b0050","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2007.07.033","article-title":"The changing epidemiology of hepatitis C virus infection in Europe","volume":"48","author":"Esteban","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2012.05.018_b0055","unstructured":"Kramer M H. The German Law on Prevention and Control of Communicable Diseases (Infektionsschutzgesetz)-Surveillance System. VHPB \u2013 Meeting, Berlin, Germany, 13-14 October 2003. www.vhpb.org\/files\/html\/Meetings_and_publications\/Presentations\/S51Kramerberlin03.pdf."},{"key":"10.1016\/j.jhep.2012.05.018_b0060","doi-asserted-by":"crossref","unstructured":"Meffre C, Le Strat Y, Delarocque-Astagneau E, Meyer JF, Coste D, Steinmetz J, et al. Prevalence of hepatitis C, France, 2004. www.invs.sante.fr\/surveillance\/hepatite_c\/easl_2006.pdf.","DOI":"10.1016\/S0168-8278(06)80047-4"},{"key":"10.1016\/j.jhep.2012.05.018_b0065","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1017\/S0950268809002143","article-title":"Estimating hepatitis C infection acquired in England, 1986\u20132000","volume":"137","author":"Balogun","year":"2009","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jhep.2012.05.018_b0070","unstructured":"Guidance for the Prevention, Testing, Treatment & Management of Hepatitis C in Primary Care, Royal College of General Practitioners (2007) http:\/\/www.patient.co.uk\/."},{"key":"10.1016\/j.jhep.2012.05.018_b0075","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199908193410802","article-title":"The prevalence of hepatitis C virus infection in the United States, 1988 through 1994","volume":"341","author":"Alter","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2012.05.018_b0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1017\/S1481803500009040","article-title":"Sentinel surveillance of HIV and hepatitis C virus in two urban emergency departments","volume":"6","author":"Houston","year":"2004","journal-title":"Can J Emerg Med"},{"key":"10.1016\/j.jhep.2012.05.018_b0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.TA.0000171464.51584.F5","article-title":"Human immunodeficiency virus, hepatitis B, and hepatitis C seroprevalence in a Canadian trauma population","volume":"59","author":"Xeroulis","year":"2005","journal-title":"J Trauma"},{"key":"10.1016\/j.jhep.2012.05.018_b0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00007435-200301000-00008","article-title":"Hepatitis C seroprevalence and risk behaviors in patients attending sexually transmitted disease clinics","volume":"30","author":"Romanowski","year":"2003","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jhep.2012.05.018_b0095","first-page":"1427","volume":"156","author":"Gully","year":"1997","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jhep.2012.05.018_b0100","first-page":"1","article-title":"The prevalence of hepatitis C in a community-based population","volume":"25\u201323","author":"Manuel","year":"1999","journal-title":"Can Commun Dis Reports"},{"key":"10.1016\/j.jhep.2012.05.018_b0105","unstructured":"Wiebe, J. Profile of Hepatitis C and Injection Drug Use in Canada: A Discussion Paper. Prepared for Hepatitis C Prevention, Support and Research Program, Population & Public Health Branch, Health Canada, 2000. http:\/\/www.phac-aspc.gc.ca\/hepc\/pubs\/prflhepciducan-prflhepcudican\/pdf\/careDiscCanada.pdf."},{"key":"10.1016\/j.jhep.2012.05.018_b0110","unstructured":"Elliott L, Blanchard JF, Dawood M, Beaudoin CM, Dinner K. The Winnipeg Injection Drug Epidemiology (W.I.D.E.) Study: A study of the epidemiology of injection drug use and HIV infection in Winnipeg, Manitoba: Final report. Winnipeg: Epidemiology Unit, Manitoba Health, 1999 (available from the Public Health Branch, Manitoba Health, 4th floor \u2013 300 Carlton Street, Winnipeg, Manitoba, CANADA, R3B 3M9)."},{"key":"10.1016\/j.jhep.2012.05.018_b0115","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2337\/diacare.26.7.1993","article-title":"The epidemiology of diabetes in the Manitoba-registered First Nation population","volume":"26","author":"Green","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhep.2012.05.018_b0120","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/hep.23429","article-title":"Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients","volume":"51","author":"Feuerstadt","year":"2010","journal-title":"Hepatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827812004187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827812004187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T16:30:34Z","timestamp":1642350634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827812004187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0168827812004187"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2012.05.018","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}